This year's Lasker-Koshland Special Achievement Award in Medical Science is conferred on Sir David Weatherall for his 50 years of dedication to biomedical research, his groundbreaking discoveries about genetic blood diseases, and his life-long passion for bringing improved medical care to the developing world.
Sir David J. Weatherall is surely in the center of the front row of the first-ranked hematologists in the world. His impact on medical genetics is second to none. It is no surprise that he has received the 2010 Lasker-Koshland Special Achievement Award in Medical Science. He adds this considerable honor to a long list of distinguished career awards, medals, and honorary degrees from an international host of universities, learned societies, and most particularly, in the view of frustrated anglophiles who fruitlessly yearn for royal recognition, the British Crown itself.
Weatherall was born, raised, and educated in Liverpool, that port city where the Mersey River meets the Irish Sea. At its peak, 40% of England's trade, huge numbers of immigrants, and many British subjects migrating to the west and the east passed through Liverpool. Weatherall comes from a long line of ''Liverpudlians.'' As a youngster, he became infused by interests in science and music and by that city's first love, football. His father was a laboratory technician who went to college at night and rose to become the chief of the analytical chemistry laboratory in a large Liverpool company as well as a council member of the Royal Society of Chemistry, but his first love was music. He was the organist and choir master of St. Nicholas Church on the Liverpool waterfront. Weatherall's mother was also devoted to music and was blessed with a beautiful contralto voice. (Weatherall and Baglioni, 1962 In the subsequent three editions, he was joined first by his long-time colleague John Clegg and subsequently by several coeditors. The last edition of this monumental contribution to hematology and clinical genetics was published in 2001. The four editions are heavily cited landmarks in medical education and are magnificent examples of interweaving of literature with personal experience. They reveal Weatherall's understanding of Darwin's precept that disorders due to gene mutations are heavily modified by environmental circumstances. Finally, they established Weatherall as one of the founders of molecular medicine and attracted many basic scientists into the field. As a result, thalassemia led the way toward the clinical applications of molecular biology.
In addition to his scientific training, Weatherall had two very important encounters in Baltimore that were to be extremely influential in his personal and professional life. In 1960, he met Stella Mayorga-Nestler in the Johns Hopkins biochemistry department of the then School of Hygiene, where she was working with Roger Herriott of DNA transformation fame. They were married in Stella's California home in 1962. A second critically important set of encounters included Mike Naughton, an excellent protein chemist who was working in the Howard Dintzis laboratory at Johns Hopkins, and John Clegg, who had joined Naughton after a brief (and stormy) sojourn in Hans Neurath's laboratory in Seattle. Weatherall asked the two protein chemists for help with a critical question on which he had been working without great success for months. Can the expected depression of beta globin chain synthesis be reliably detected biosynthetically in the reticulocytes of patients with beta thalassemia? Clegg suggested that a carboxymethylcellulose column and a buffer containing 8 molar urea and 6-mercaptoethanol might keep the alpha, gamma, and beta globin chains separated, prevent their aggregation, permit their independent isolation, and, hence, allow the determination of their specific activities after incubation of blood from thalassemia patients with a 3 H-or 14 C-labeled amino acid (Weatherall et al., 1965) . Though the method was malodorous and the fraction collector permanently encrusted with crystals of urea, it worked and clearly documented that thalassemia is a disorder of unbalanced globin synthesis. Though almost entirely replaced by modern DNA-based methods, it remains a valuable if unwieldy approach to the diagnosis of microcytic anemias of unknown etiology. Clegg and Weatherall have been colleagues ever since.
Following his remarkably productive sojourn in Baltimore, Weatherall returned to the University of Liverpool where, with his colleagues Clegg and Bill Wood, a young trainee, he established a superb clinical research program in hematology. He rose to the rank of Professor of Haematology and remained in Liverpool until 1974 when he moved, again with his two close colleagues, to the University of Oxford to be the Nuffield Professor and then the Regius Professor of Medicine and where he founded a research institute now named the Weatherall Institute of Molecular Medicine. The institute, the first of its kind in Europe, opened in 1989 and now has a staff of over 400. It is devoted to biomedical research with a strong clinical component. He retired from the Oxford faculty in 2000 but remains a distinguished participant in the institute, now directed by his former student, Douglas Higgs, a superb physician scientist.
In addition to his many book chapters and The Thalassaemia Syndromes, Weatherall has been a coauthor of over 500 articles, most of which focus on thalassemia, malaria, and the hemoglobinopathies. In the process of studying thalassemia, he has traveled the world many times over and has trained a substantial cadre of investigators who direct important clinical and clinical research programs particularly in Southeast Asia. Much of his most original clinical research effort has illuminated the alpha thalassemia syndromes, conditions particularly prevalent in Southeast Asia.
In 1974, when reverse transcriptase permitted the development of isotopically labeled cDNA probes, both Weatherall's group (Ottolenghi et al., 1974 ) and a group assembled by Y.W. Kan (Taylor et al., 1974) demonstrated that complete alpha globin gene deletion plays a critical role in the development of severe (and usually fatal) hydrops fetalis with Bart's hemoglobinemia. The two papers were published back to back in the same issue of Nature. Later it was shown that unusual point mutations may also inhibit or even arrest alpha globin gene expression. In fact, in 1975, Weatherall and Clegg demonstrated that a termination codon mutation in one of the four alpha genes can lead to an abnormally elongated alpha chain and an unstable messenger RNA producing alpha + thalassemia, but deletion is the predominant genetic lesion in alpha 0 thalassemia.
The development of reasonably specific beta globin cDNA probes that permitted interpretable Southern blots was somewhat more difficult than that of alpha globin cDNA probes because of overlap of beta globin DNA sequences with delta and gamma sequences. In 1976, a group assembled by Weatherall and headed by Sergio Ottolenghi demonstrated that both delta-beta thalassemia and the form of hereditary persistence of fetal hemoglobin (HPFH) found in Africans are due to extensive gene deletions (Ottolenghi et al., 1976) . The subtle but important differences between the two that lead to considerably higher gamma gene expression in HPFH were detected later by several groups. Only 2 years later such a probe was utilized by Orkin and his coworkers to exclude homozygous delta-beta thalassemia in a first trimester Turkish fetus at risk (Orkin et al., 1978) .
The alpha thalassemias continued to capture Weatherall's interest and attention, and when Douglas Higgs joined his laboratory as a budding physician scientist, that interest blossomed into major findings. By this time, Weatherall's research unit had become a reference laboratory for clinicians throughout Great Britain, southern Europe, and Southeast Asia. Among these referrals were three blood samples from male patients of northern European origin, each of whom had both mental retardation and hemoglobin H disease, a form of alpha thalassemia usually due to three alpha gene deletions. Analysis of the alpha genes of the patients and their parents revealed that one parent did indeed have two alpha gene deletions (as expected), but the other had an entirely normal complement of four alpha genes. The patients had only two deletions. Clearly another mutation must have been present to suppress the expression of the intact alpha genes, and that mutation was likely to cause the mental retardation as well. That was a puzzle to be solved considerably later in a brilliant series of studies by Higgs and his colleagues. These studies demonstrated an X-linked helicase deficiency in the male patients and subtelomeric deletions on chromosome 16 in others that were shown to be responsible for reduced alpha globin gene expression and were presumably responsible for the mental retardation (Gibbons and Higgs, 2000) .
The remarkable copresentation of mental retardation and alpha thalassemia stimulated Weatherall and Higgs to focus on the molecular anatomy of the alpha globin gene cluster. They provided the first RFLP map of the cluster and showed that it offered an excellent site for linkage analysis (Higgs et al., 1986) . Along the way, they defined the alpha globin gene locus control region. The experience launched Higgs' fine career.
Weatherall is a broadly interested hematologist. Though he made many important contributions to the genetic basis of thalassemia, he never lost an opportunity to explore its treatment and prevention. Immediately after Propper and his coworkers suggested that daily continuous subcutaneous administration of deferoxamine might prolong the lives of multiply transfused thalassemia patients with consequent iron overload (Propper et al., 1977) , Pippard and Weatherall showed that a 5 day overnight regimen would eliminate iron nearly as well but be much more acceptable to patients (Pippard et al., 1977) . They were correct, but the long gaps in which no chelator could be present in the blood diminished the efficacy of the treatment. On the other hand, many more patients could accept the regimen. It became the standard of care until very recently when deferisirox, an orally active chelator with a long plasma half-life, became available.
Though Weatherall was rightly doubtful that the globin chain synthesis system that he had developed with Clegg and Naughton (Weatherall et al., 1965) could be reliably applied in prenatal diagnosis using blood obtained from the placenta, he changed his mind when he saw the initial results of the efforts of Kan and Alter and their colleagues (Kan et al., 1972) . He moved aggressively to establish a highly successful prenatal detection system in England that became a model of its kind (Old et al., 1982) and then adopted more practical molecular methods when they became available.
As Weatherall began to pass the torch of leadership of laboratory-based research to Higgs, he directed his considerable energy to his first interest, the plight of poor patients in malaria zones who endure high rates of both malarial and nonmalarial infections and of inherited hemoglobinopathies. His publications in this important area are many, but one of the most interesting is his finding in Papua, New Guinea that a single alpha gene deletion and particularly two such deletions provide high protection from both malarial and nonmalarial infections (Allen et al., 1997) . How a mild inherited disorder of hemoglobin synthesis, limited in its expression to the red cell and manifested only as microcytosis (unusually small red blood cells), can influence nonmalarial infection rates requires much more understanding of host defense than we have currently. In another fascinating study, Weatherall and his colleagues demonstrated that HbE/thalassemia, a very common disorder in Southeast Asia, provides very little protection from malaria caused by the parasite Plasmodium vivax. In fact vivax malaria infection is one of the factors that increases the severity of that particular thalassemia syndrome (O'Donnell et al., 2009) . Finally, Weatherall's efforts have provided students of thalassemia with insights into the clinical course of the disease as patients age (O'Donnell et al., 2007) . His clinics in Sri Lanka are invaluable ''classrooms'' for young North American and British students of the disease, particularly for those who wish to find better treatments, to learn quickly about its manifestations and for those who intend to contribute to the care of patients desperately in need. Even more important is Weatherall's creation of an Asian Thalassaemia Network in which experts in India and Thailand give technical assistance to their colleagues in less developed countries such as Bangladesh and Cambodia.
Meanwhile, Weatherall continues to travel to major sites of the thalassemia syndromes, urge world health authorities and private foundations to pay attention to the inherited hemoglobinopathies, tell anyone who will listen about the impending world impact of the disorders, and try to do his best to relieve the suffering that these common inherited diseases bring to those who can least afford to deal with them. He does all this with gem-like intelligence and indefatigable determination, both mixed with marvelous humor and deep interest in what his colleagues are doing. Indeed, life in academic medicine is really all about working with great colleagues. I have been blessed with many, none more enjoyable or admirable than Sir David J. Weatherall.
